LPCAT1 and breast carcinoma: These data are also confirmed by the results of Abdelzaher and Mostafa [14], which describe links between LPCAT1 immunostaining and high-grade, advanced TNM stage, T stage and lymph node stage in their series of 80 breast cancer patients.